In Illinois, researchers discovered how the most deadly pediatric brain tumor, diffuse intrinsic pontine glioma, develops and found a compound that can flip the switch on cancer-promoting genes turning them off so the tumor shrinks. Researchers used biopsied tumor samples from patients to create the lab models and it took less than two years for them to make the discovery. Considering only 5 percent of children with this brain tumor survive, being able to shrink tumors and increase survival rates in animal models is giving major hope for children and their parents. Clinical trials will begin at the Ann & Robert H. Lurie Children’s Hospital of Chicago by the end of the year.
Latest article
Kiwi company turns kiwi waste into leather
In New Zealand, a startup called KiwiLeather Innovations is building a business converting rejected kiwifruit into a leather alternative.
According to Fresh Plaza, over...
UPSIDE Foods serves cultivated chicken at Indy 500 ahead of state ban
In Indiana, UPSIDE Foods served cultivated chicken sandwiches during the recent Indianapolis 500 as it called the state’s upcoming ban on such products “un-American.”...
Bee-free honey maker MeliBio acquired by FoodYoung Labs
In California, MeliBio, a pioneer in bee-free food, has been acquired by Switzerland-based foodtech FoodYoung Labs for an undisclosed sum.
MeliBio has earned global...